Ayurcann signs supply agreement to have products sold on CannMart and Patients Choice platforms.
Ayurcann Holdings (CSE: AYUR) CEO Igal Sudman joined Steve Darling from Proactive to shares news the company has signed a two supply deals with medical cannabis product suppliers, CannMart Inc and Patient Choice to sell branded products directly to medical patient consumers.
Sudman shared with Proactive consumers will soon be able to choose Ayurcann products like XPLOR Pure CBD 1000 Tincture, Fuego Vena Grad 1g Vape Cartridge, Fuego Cheri Amour 1g Vape Cartridge, Fuego La Padres 1g Vape Cartridge, and finally the Xplor Balanced 250 Tincture.
Quick facts: Ayurcann Holdings Corp.
About Ayurcann Holdings Corp.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
About Cannmart Inc.
Cannmart provides Canadian medical customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators. The Company also distributes licensed and in-house branded cannabis and cannabis-derived products in Canada through a number of provincial government control boards and retailing bodies.